At the Health Evolution Summit last week, I facilitated a meeting of about 25 corporate venture capital groups. To lighten up the discussion, I asked the group, comprised of payers, providers, health IT and tech companies and a smattering of pharma/medtech companies, to vote on the buzzword that they can’t stand to hear ever again […]